Immunocore Holdings (IMCR) Net Income towards Common Stockholders Growth (3y) (2026)
Immunocore Holdings (IMCR) Net Income towards Common Stockholders Growth (3y) (2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Net Income Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
767,934.24 Bn |
767,934.20 Bn |
- |
- |
| 2 |
Belite Bio |
55,234.00 Bn |
55,234.00 Bn |
- |
84.25% |
| 3 |
Quantum Biopharma |
17,823.14 Bn |
17,823.14 Bn |
- |
-10.84% |
| 4 |
Legend Biotech |
3,624.50 Bn |
3,624.21 Bn |
242.10 Mn |
26.38% |
| 5 |
Akari Therapeutics |
1,745.73 Bn |
1,745.73 Bn |
- |
-46.86% |
| 6 |
Evaxion A |
1,540.85 Bn |
1,540.84 Bn |
- |
34.98% |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
112.57 Bn |
105.33 Bn |
2.59 Bn |
13.80% |
| 9 |
Abivax |
93.46 Bn |
93.46 Bn |
- |
- |
| 10 |
Immunocore Holdings |
1.46 Bn |
616.35 Mn |
106.24 Mn |
38.68% |
| Date | Value |
|---|
| Mar 31, 2026 |
38.68% |
